Bionovo (NASDAQ: BNVI.OB) was an American biotechnology company focused on the discovery and development of botanically derived treatments for women's health and cancer based in Emeryville, California. The company had two drug candidates in U.S. Food and Drug Administration (FDA) clinical trials- Menerba (formerly known as MF101) a selective estrogen receptor beta agonist for hot flashes associated with menopause and Bezielle (formerly BZL101) for advanced breast cancer.

Property Value
dbo:abstract
  • Bionovo (NASDAQ: BNVI.OB) was an American biotechnology company focused on the discovery and development of botanically derived treatments for women's health and cancer based in Emeryville, California. The company had two drug candidates in U.S. Food and Drug Administration (FDA) clinical trials- Menerba (formerly known as MF101) a selective estrogen receptor beta agonist for hot flashes associated with menopause and Bezielle (formerly BZL101) for advanced breast cancer. The company has ceased activity and its stock, although still listed, not moved from 0,00 USD since the end of 2012. No statement has been made by the management, nor any indication has been given that the company is still active. The last press statement was about the sell of all the technical equipment and lay off of 90% of the staff. In short words, the company is as good as bankrupted and shut down, although the management never officially admitted it. (en)
dbo:industry
dbo:numberOfEmployees
  • 8 (xsd:integer)
dbo:type
dbo:wikiPageEditLink
dbo:wikiPageExternalLink
dbo:wikiPageExtracted
  • 2017-09-27 10:38:57Z (xsd:date)
  • 2018-04-27 19:17:22Z (xsd:date)
  • 2019-03-27 11:02:46Z (xsd:date)
dbo:wikiPageHistoryLink
dbo:wikiPageID
  • 27903748 (xsd:integer)
dbo:wikiPageLength
  • 10618 (xsd:integer)
  • 10924 (xsd:integer)
dbo:wikiPageModified
  • 2018-02-24 00:02:24Z (xsd:date)
  • 2019-03-27 10:57:02Z (xsd:date)
dbo:wikiPageOutDegree
  • 46 (xsd:integer)
dbo:wikiPageRevisionID
  • 827309143 (xsd:integer)
  • 889698026 (xsd:integer)
dbo:wikiPageRevisionLink
dbp:homepage
dbp:industry
dbp:keyPeople
  • Isaac Cohen, Founder and CEO, Mary Tagliaferri, Founder, President and CMO (en)
dbp:locationCity
dbp:locationCountry
  • United States (en)
dbp:logo
  • Bionovo Logo.jpg (en)
dbp:name
  • Bionovo (en)
dbp:numEmployees
  • 8 (xsd:integer)
  • ParseResult(8,None,None)
dbp:type
dbp:wikiPageUsesTemplate
dct:subject
rdf:type
rdfs:comment
  • Bionovo (NASDAQ: BNVI.OB) was an American biotechnology company focused on the discovery and development of botanically derived treatments for women's health and cancer based in Emeryville, California. The company had two drug candidates in U.S. Food and Drug Administration (FDA) clinical trials- Menerba (formerly known as MF101) a selective estrogen receptor beta agonist for hot flashes associated with menopause and Bezielle (formerly BZL101) for advanced breast cancer. (en)
rdfs:label
  • Bionovo (en)
owl:sameAs
foaf:isPrimaryTopicOf
foaf:name
  • Bionovo (en)
is foaf:primaryTopic of